Myriad Genetics, Inc.MYGNNASDAQ
Loading
PB Ratio HistoryNormalizing
Percentile Rank14
3Y CAGR+5.7%
5Y CAGR-1.4%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+5.7%/yr
vs -8.2%/yr prior
5Y CAGR
-1.4%/yr
Recent acceleration
Acceleration
+13.9pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineNormalizing
PeriodValueYoY Change
20251.56-12.0%
20241.77-12.4%
20232.02+53.3%
20221.32-40.4%
20212.22+32.2%
20201.68+116.6%
20190.77-58.3%
20181.86-31.0%
20172.69+18.5%
20162.27-